JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has a cash flow conversion efficiency ratio of 0.095x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.62 Billion ≈ $39.19 Million USD) by net assets (Rs38.06 Billion ≈ $411.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) net asset quality to measure how much of total assets are equity-financed.
JB Chemicals & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2026)
This chart illustrates how JB Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check JBCHEPHARM operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
JB Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Silgan Holdings Inc
NYSE:SLGN
|
-0.345x |
|
De Grey Mining Ltd
AU:DEG
|
0.000x |
|
Minor International Public Company Limited
BK:MINT
|
0.094x |
|
Navin Fluorine International Limited
NSE:NAVINFLUOR
|
0.071x |
|
JUSUNG ENGINEERING Co. Ltd
KQ:036930
|
-0.027x |
|
Corporacion America Airports
NYSE:CAAP
|
0.054x |
|
Tanger Factory Outlet Centers Inc
NYSE:SKT
|
0.055x |
|
Farsoon Technology Co. Ltd. A
SHG:688433
|
N/A |
Annual Cash Flow Conversion Efficiency for JB Chemicals & Pharmaceuticals Limited (2006–2026)
The table below shows the annual cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2026. For the full company profile with market capitalisation and key ratios, see market value of JB Chemicals & Pharmaceuticals Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs41.59 Billion ≈ $449.80 Million |
Rs7.11 Billion ≈ $76.85 Million |
0.171x | -35.00% |
| 2025-03-31 | Rs34.33 Billion ≈ $371.30 Million |
Rs9.02 Billion ≈ $97.60 Million |
0.263x | -4.02% |
| 2024-03-31 | Rs29.23 Billion ≈ $316.15 Million |
Rs8.01 Billion ≈ $86.58 Million |
0.274x | +8.58% |
| 2023-03-31 | Rs24.80 Billion ≈ $268.24 Million |
Rs6.26 Billion ≈ $67.66 Million |
0.252x | +217.05% |
| 2022-03-31 | Rs21.39 Billion ≈ $231.28 Million |
Rs1.70 Billion ≈ $18.40 Million |
0.080x | -54.17% |
| 2021-03-31 | Rs18.13 Billion ≈ $196.12 Million |
Rs3.15 Billion ≈ $34.04 Million |
0.174x | -9.35% |
| 2020-03-31 | Rs14.38 Billion ≈ $155.51 Million |
Rs2.75 Billion ≈ $29.78 Million |
0.191x | +47.08% |
| 2019-03-31 | Rs14.83 Billion ≈ $160.37 Million |
Rs1.93 Billion ≈ $20.88 Million |
0.130x | +52.83% |
| 2018-03-31 | Rs14.44 Billion ≈ $156.20 Million |
Rs1.23 Billion ≈ $13.31 Million |
0.085x | -41.88% |
| 2017-03-31 | Rs13.66 Billion ≈ $147.71 Million |
Rs2.00 Billion ≈ $21.65 Million |
0.147x | +14.95% |
| 2016-03-31 | Rs10.95 Billion ≈ $118.46 Million |
Rs1.40 Billion ≈ $15.10 Million |
0.128x | +0.15% |
| 2015-03-31 | Rs9.95 Billion ≈ $107.59 Million |
Rs1.27 Billion ≈ $13.70 Million |
0.127x | +1049.86% |
| 2014-03-31 | Rs10.43 Billion ≈ $112.78 Million |
Rs-139.78 Million ≈ $-1.51 Million |
-0.013x | -116.10% |
| 2013-03-31 | Rs10.20 Billion ≈ $110.34 Million |
Rs849.32 Million ≈ $9.19 Million |
0.083x | -90.82% |
| 2012-03-31 | Rs9.70 Billion ≈ $104.90 Million |
Rs8.80 Billion ≈ $95.14 Million |
0.907x | +368.67% |
| 2011-03-31 | Rs6.92 Billion ≈ $74.79 Million |
Rs1.34 Billion ≈ $14.47 Million |
0.194x | -9.87% |
| 2010-03-31 | Rs5.68 Billion ≈ $61.44 Million |
Rs1.22 Billion ≈ $13.19 Million |
0.215x | +10.50% |
| 2009-03-31 | Rs4.69 Billion ≈ $50.71 Million |
Rs911.05 Million ≈ $9.85 Million |
0.194x | +210.91% |
| 2008-03-31 | Rs4.53 Billion ≈ $48.99 Million |
Rs283.11 Million ≈ $3.06 Million |
0.062x | +17.36% |
| 2007-03-31 | Rs4.18 Billion ≈ $45.26 Million |
Rs222.82 Million ≈ $2.41 Million |
0.053x | -21.99% |
| 2006-03-31 | Rs3.30 Billion ≈ $35.73 Million |
Rs225.51 Million ≈ $2.44 Million |
0.068x | -- |
About JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dos… Read more